REDEFINE 1 analyses presented at The Menopause Society 2026 meeting found mean weight loss of 23.1% to 26.7% across pre-, peri-, and postmenopausal women.
|Articles|July 12, 2022
Daily OTC Pearl: Instant Sleep
Author(s)Saro Arakelians, PharmD
Advertisement
OTC/Lifestyle Pearl of the Day: Instant Sleep
Indication: Instant Sleep is intended to aid with falling asleep faster and staying asleep longer.
Insight:
- Natural sleep aid contains a triple strength blend of herbal sleep support ingredients extracted from plants that have long been used to regulate sleep.
- L-theanine promotes both physical and mental relaxation.
- Melatonin helps to fall asleep and gives a high quality of rest better than you will find in any sleep supplement.
- Ingredients: L-Theanine, 5-HTP, melatonin, magnesium, mucuna pruriens extract, GABA, and phellodendron root (herb powder) that has many sleep support properties.
- Directions: Two capsules before bedtime with 8 oz of water.
Source:
Advertisement
Related to this article
Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.
Sea buckthorn is a commonly used herbal for respiratory health—US pharmacists are knowledgeable in educating patients on herbals, especially during the cold season.
Community pharmacies are access points, safe places, and sources of stability when everything else feels uncertain.
In the phase 3 B-Well trials, about 1 in 5 adults reached functional cure after a fixed course, but a boxed warning makes monitoring key for pharmacists.
Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
The once-nightly drop, previously approved to reverse pupil dilation, met its primary end point in 2 phase 3 trials, with conjunctival hyperemia most common.
Isatuximab on-body injector enables quick, hyaluronidase-free subcutaneous dosing, reducing reactions and easing multiple myeloma clinic workflows.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
2
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
3
Recap: Tirzepatide Is Approved to Cut Cardiovascular Risk in Type 2 Diabetes
4
Oncology Pharmacists Reduce Adverse Drug Reactions in Hematologic Cancer Care
5